Malignant pleural effusion (MPE ) is due tumor which arises from the mesothelium or metastases from tumor origniating other sites. In large, for undiagnosed unilateral pleural effusions, the most frequent and important diagnosis to be established or excluded is malignancy. Cell block is prepared from residual fluid which is centrifuged or is naturally sedimenting to obtain clots at the bottom of the container. The cell block technique is simple, relatively non-invasive, reproducible and has a high yield for malignant plerual effusion. It plays an important role in the diagnosis, guiding the treatment of maligant pleural effusion. Herein, we summarize the technologys which make the cell block, the differential diagnostic value when multiple ...
Malignant pleural effusion (MPE) is a condition caused by primary malignant tumors in the pleura or ...
MPEs are a common and important cause of cancer-related mortality and morbidity. Prompt diagnosis us...
Pleural effusion biomarkers and CT findings in diagnosing malignant pleural mesotheliom
The value of cytological examination of pleural effusions is widely recognized and well documented. ...
Introduction- Lung cancer is the most common primary tumor associated with malignant pleural effusio...
Malignant pleural effusions (MPEs) are the second leading cause of exudative pleural effusions after...
Malignant pleural effusion (MPE) is defined as an effusion that occurs in association with malignanc...
RATIONALE: Cytological analysis of pleural effusions (PEs) has a sensitivity of approximately 60%. W...
Pleural effusion is a common disease that is caused by pulmonary carcinomas and other malignant tumo...
BACKGROUND Cytological evaluation of effusion fluid has become integral part of management especial...
Background: With the introduction of cytospin, the sensitivity of diagnosing malignancies has increa...
Etiology diagnosis of pleural effusion is a commonly encountered yet challenging problem. How to mak...
Background and Objectives: Diagnostic issues arise in everyday practice to reach a conclusive diagno...
Objective: To evaluate the feasibility of malignant pleural effusions (MPE) as surrogate samples for...
Malignant pleural effusion is a common complication of cancer and denotes a poor prognosis. It usual...
Malignant pleural effusion (MPE) is a condition caused by primary malignant tumors in the pleura or ...
MPEs are a common and important cause of cancer-related mortality and morbidity. Prompt diagnosis us...
Pleural effusion biomarkers and CT findings in diagnosing malignant pleural mesotheliom
The value of cytological examination of pleural effusions is widely recognized and well documented. ...
Introduction- Lung cancer is the most common primary tumor associated with malignant pleural effusio...
Malignant pleural effusions (MPEs) are the second leading cause of exudative pleural effusions after...
Malignant pleural effusion (MPE) is defined as an effusion that occurs in association with malignanc...
RATIONALE: Cytological analysis of pleural effusions (PEs) has a sensitivity of approximately 60%. W...
Pleural effusion is a common disease that is caused by pulmonary carcinomas and other malignant tumo...
BACKGROUND Cytological evaluation of effusion fluid has become integral part of management especial...
Background: With the introduction of cytospin, the sensitivity of diagnosing malignancies has increa...
Etiology diagnosis of pleural effusion is a commonly encountered yet challenging problem. How to mak...
Background and Objectives: Diagnostic issues arise in everyday practice to reach a conclusive diagno...
Objective: To evaluate the feasibility of malignant pleural effusions (MPE) as surrogate samples for...
Malignant pleural effusion is a common complication of cancer and denotes a poor prognosis. It usual...
Malignant pleural effusion (MPE) is a condition caused by primary malignant tumors in the pleura or ...
MPEs are a common and important cause of cancer-related mortality and morbidity. Prompt diagnosis us...
Pleural effusion biomarkers and CT findings in diagnosing malignant pleural mesotheliom